CAM
VRTX icon

Congress Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$83.7M Buy
188,004
+428
+0.2% +$191K 0.57% 65
2025
Q1
$90.9M Buy
187,576
+40,427
+27% +$19.6M 0.68% 54
2024
Q4
$59.3M Sell
147,149
-41,431
-22% -$16.7M 0.4% 95
2024
Q3
$87.7M Buy
188,580
+6,919
+4% +$3.22M 0.6% 76
2024
Q2
$85.1M Buy
181,661
+180,286
+13,112% +$84.5M 0.61% 75
2024
Q1
$575K Hold
1,375
﹤0.01% 318
2023
Q4
$559K Sell
1,375
-19
-1% -$7.73K ﹤0.01% 337
2023
Q3
$485K Sell
1,394
-125
-8% -$43.5K ﹤0.01% 338
2023
Q2
$535K Hold
1,519
﹤0.01% 328
2023
Q1
$479K Sell
1,519
-62
-4% -$19.5K ﹤0.01% 334
2022
Q4
$457K Sell
1,581
-20
-1% -$5.78K ﹤0.01% 342
2022
Q3
$464K Sell
1,601
-17,578
-92% -$5.09M 0.01% 329
2022
Q2
$5.4M Buy
19,179
+17,028
+792% +$4.8M 0.05% 211
2022
Q1
$561K Sell
2,151
-1,302
-38% -$340K ﹤0.01% 330
2021
Q4
$758K Sell
3,453
-666
-16% -$146K 0.01% 321
2021
Q3
$747K Sell
4,119
-337,617
-99% -$61.2M 0.01% 310
2021
Q2
$68.9M Sell
341,736
-615
-0.2% -$124K 0.58% 77
2021
Q1
$73.6M Buy
342,351
+29,923
+10% +$6.43M 0.66% 77
2020
Q4
$73.8M Buy
312,428
+10,938
+4% +$2.59M 0.7% 75
2020
Q3
$82M Buy
301,490
+2,844
+1% +$774K 0.89% 62
2020
Q2
$86.7M Sell
298,646
-5,099
-2% -$1.48M 1.03% 44
2020
Q1
$72.3M Sell
303,745
-3,672
-1% -$874K 1.1% 42
2019
Q4
$67.3M Sell
307,417
-1,439
-0.5% -$315K 0.82% 62
2019
Q3
$52.3M Buy
308,856
+5,779
+2% +$979K 0.67% 76
2019
Q2
$55.6M Buy
303,077
+22,210
+8% +$4.07M 0.71% 74
2019
Q1
$51.7M Buy
280,867
+2,319
+0.8% +$427K 0.68% 74
2018
Q4
$46.2M Buy
278,548
+17,172
+7% +$2.85M 0.69% 72
2018
Q3
$50.4M Buy
261,376
+8,644
+3% +$1.67M 0.65% 73
2018
Q2
$43M Buy
+252,732
New +$43M 0.59% 79
2013
Q3
Sell
-53,222
Closed -$4.26M 231
2013
Q2
$4.26M Buy
+53,222
New +$4.26M 0.13% 111